EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review)

Xiaotong Ma, Ran Wei, Anni Song, Xinyi Zhang, Jianpeng Zou, Shijie Hao

International Journal of Molecular Medicine · 2025

DOI: 10.3892/ijmm.2025.5599 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Xiaotong Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Histone Deacetylases. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is a major global health threat, as its incidence and mortality rates continue to rise, highlighting the urgent need for effective therapeutic strategies. Histone deacetylase 4 (HDAC4), a member of class IIa HDACs, has attracted increasing attention in recent years for its role in CVD. Studies have shown that HDAC4 can influence the development and progression of CVD such as cardiac hypertrophy, hypertension and atherosclerosis by regulating key pathophysiological processes including inflammation, fibrosis and apoptosis. The present review focuses on the functional roles of HDAC4 in CVD and examines the effects of pharmacological agents and physical exercise on its expression. Future research should further elucidate the molecular mechanisms underlying HDAC4's involvement in CVD to provide new theoretical foundations for clinical diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHistone DeacetylasesHumansAnimalsHistone Deacetylase InhibitorsMolecular Targeted TherapyRepressor Proteins

Stichwörter der Autor:innen

cardiovascular diseasesfunctionhistone deacetylase 4mechanism of actiontherapeutic target

Substanzen

Histone DeacetylasesHDAC4 protein, humanHistone Deacetylase InhibitorsRepressor Proteins

Autor:innen und Institutionen

  • College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China.
  • Department of Rehabilitation and Physiotherapy, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, Shandong 250011, P.R. China.

Zitieren

APA

Ma, X., Wei, R., Song, A., Zhang, X., Zou, J., & Hao, S. (2025). Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5599

Vancouver

Ma X, Wei R, Song A, Zhang X, Zou J, Hao S. Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review). International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5599

BibTeX
@article{Ma2025,
  author = {Ma, Xiaotong and Wei, Ran and Song, Anni and Zhang, Xinyi and Zou, Jianpeng and Hao, Shijie},
  title = {Histone deacetylase 4: A therapeutic target for cardiovascular diseases (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2025},
  doi = {10.3892/ijmm.2025.5599}
}
Kostenlos starten →